The Safety Platform for Emergency vACcines (SPEAC) is a Brighton Collaboration project funded in whole by the Coalition for Epidem...

On 8 and 9 November 2022, the Maternal Immunization Working Group (MIWG) held an in-person and online hybrid meeting. The objectiv...

Within the context of the Covid19 Vaccine Introduction Program (COVIP), the CARESAFE project builds on existing CDC and Task Force...

Rare adverse events following immunization (AEFIs) occurring in <1 per 10,000 vaccine recipients may not be detected in prelice...

Effective safety monitoring of COVID-19 vaccines must go beyond the use of passive surveillance, which is typically used to...

In recognition of the increasing importance of viral vectors for the development of new vaccines and the need to understand their...

Randomised controlled trials (RCTs) are considered the gold standard for assessing the efficacy of drugs prior to their approval f...

Background: In 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovale...

About Immunization in PregnancyImmunization in pregnancy is a promising public health strategy to reduce illness and death among p...

The Brighton Collaboration (BC) Viral Vector Vaccines Safety Working Group (V3SWG) was renamed to Benefit-Risk Assessment of VAcci...